BioCentury | Jan 27, 2014
Company News

Phosphagenics, Novartis, Themis Medicare Ltd. sales and marketing update

...Voveran and Instanac. Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Themis Medicare Ltd....
BioCentury | Apr 8, 2013
Company News

Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

...be eligible for milestones, plus royalties (see BioCentury, March 12, 2012). In 2011, Phosphagenics granted Themis Medicare Ltd....
BioCentury | Mar 12, 2012
Company News

Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

...diclofenac, an NSAID delivered using the TPM delivery system. Terms were not disclosed. Phosphagenics granted Themis Medicare Ltd....
BioCentury | Nov 7, 2011
Company News

Phosphagenics, Themis Medicare sales and marketing update

...a Phase Ib trial of the gel in 2009. Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Themis Medicare Ltd....
Items per page:
1 - 4 of 4
BioCentury | Jan 27, 2014
Company News

Phosphagenics, Novartis, Themis Medicare Ltd. sales and marketing update

...Voveran and Instanac. Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Novartis AG (NYSE:NVS; SIX:NOVN), Basel, Switzerland Themis Medicare Ltd....
BioCentury | Apr 8, 2013
Company News

Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

...be eligible for milestones, plus royalties (see BioCentury, March 12, 2012). In 2011, Phosphagenics granted Themis Medicare Ltd....
BioCentury | Mar 12, 2012
Company News

Phosphagenics, Nippon Zoki Pharmaceuticals Co. Ltd. deal

...diclofenac, an NSAID delivered using the TPM delivery system. Terms were not disclosed. Phosphagenics granted Themis Medicare Ltd....
BioCentury | Nov 7, 2011
Company News

Phosphagenics, Themis Medicare sales and marketing update

...a Phase Ib trial of the gel in 2009. Phosphagenics Ltd. (ASX:POH; OTCQX:PPGNY), Melbourne, Australia Themis Medicare Ltd....
Items per page:
1 - 4 of 4